SFG
CYTK icon

Steward Financial Group’s Cytokinetics CYTK Stock Holding History

Steward Financial Group’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$0 Buy
+12
New +$400 ﹤0.01% 1375
2023
Q2 		– Sell
-12
Closed – – 590
2023
Q1 		$0 Buy
+12
New +$490 ﹤0.01% 769

Other funds holding CYTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Steward Financial Group's CYTK Position: Q3 2023 in Review

Steward Financial Group opened a new position in Cytokinetics (CYTK) in Q3 2023: 12 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #1375 among its holdings. This is a return to the name: Steward Financial Group previously reported a position in CYTK as recently as Q1 2023.

Steward Financial Group first reported a position in CYTK in Q1 2023 and has held it in 2 quarters since. 250 funds tracked by Wall St. Rank hold CYTK as of Q3 2023.

  • Steward Financial Group held 12 shares of Cytokinetics worth $0 as of Q3 2023.
  • Cytokinetics was a new Steward Financial Group position in Q3 2023.
  • Cytokinetics made up ﹤0.01% of Steward Financial Group's portfolio in Q3 2023, its #1375 holding.
  • Steward Financial Group first reported a position in Cytokinetics in Q1 2023 and has held it in 2 quarters since.
  • 250 funds tracked by Wall St. Rank held Cytokinetics as of Q3 2023.

Based on Steward Financial Group's 13F filing for Q3 2023, filed 23 Oct 2023.